Analys av Danske Bank efter bokslutskommuniké
Sprint Bioscience - Next frontier of drug discoverySprint Bioscience is an innovative company focused on early-stage drug development,providing novel drug candidates within the cancer field. Its strategy is to outperformresearch productivity in preclinical phase, identifying and running tailor-made drugdevelopment projects leanly and effectively. After development, the company out-licensespromising and high-quality projects to the global pharma industry through milestone androyalty agreements. Click here to access report